文献速递肾移植肾血管病与高血压

肾移植受者新发主要心血管事件:一项比较性匹配队列研究

De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该研究利用韩国全国健康保险数据库,将肾移植受者与透析对照及一般人群对照按1:1匹配,每组4156人,随访4.7年。肾移植受者新发主要不良心血管事件风险低于透析对照(aHR 0.16,95%CI 0.12-0.20,P<.001),与一般人群对照相近(aHR 0.81,95%CI 0.52-1.27,P=.365);肾移植受者一旦发生新发主要不良心血管事件,全因死亡风险升高。

要点

  • 肾移植受者新发主要不良心血管事件发生率为3.7例/1000人年,低于透析对照的21.7例/1000人年。
  • 肾移植受者主要不良心血管事件风险低于透析对照(aHR 0.16),与一般人群对照相近(aHR 0.81)。
  • 肾移植受者发生新发主要不良心血管事件与全因死亡风险升高相关,与死亡删失的移植物失败无关。

核心结论

  • 肾移植受者新发主要不良心血管事件明显低于透析患者,与一般人群风险相近,但一旦发生则与全因死亡风险升高相关。

研究设计与样本

  • 利用韩国全国健康保险数据库识别肾移植受者,并与无既往主要不良心血管事件的透析对照和一般人群对照按1:1匹配,三组各纳入4156人,随访4.7年。
  • 主要终点为新发主要不良心血管事件,包括心肌梗死、冠状动脉血运重建和缺血性卒中;次要终点为肾移植受者的全因死亡和死亡删失的移植物失败。

主要发现

  • 新发主要不良心血管事件在肾移植受者、透析对照和一般人群对照中分别为3.7、21.7和2.5例/1000人年。
  • 肾移植受者主要不良心血管事件风险低于透析对照(aHR 0.16,95%CI 0.12-0.20,P<.001)。
  • 肾移植受者与一般人群对照的主要不良心血管事件风险相近(aHR 0.81,95%CI 0.52-1.27,P=.365)。
  • 无论年龄、性别及是否合并高血压、糖尿病和血脂异常,肾移植受者与一般人群组的主要不良心血管事件风险均相近。
  • 在肾移植受者中,新发主要不良心血管事件与全因死亡风险升高相关,但与死亡删失的移植物失败无关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although cardiovascular disease is known to be one of the leading causes of death after kidney transplantation (KT), evidence on the risk difference of de novo major adverse cardiovascular events (MACEs) in kidney transplant recipients (KTRs) compared with that in dialysis patients or the general population (GP) remains rare. METHODS: We identified KTRs using the nationwide health insurance database in South Korea and then 1:1 matched them with the dialysis and GP controls without a pre-existing MACE. The primary endpoint was defined as de novo MACEs consisting of myocardial infarction, coronary revascularization and ischemic stroke. The secondary endpoints were all-cause mortality and death-censored graft failure (DCGF) in KTRs. RESULTS: We included 4156 individuals in each of the three groups and followed them up for 4.7 years. De novo MACEs occurred in 3.7, 21.7 and 2.5 individuals per 1000 person-years in the KTRs, dialysis controls and GP controls, respectively. KTRs showed a lower MACE risk {adjusted hazard ratio (aHR) 0.16 [95% confidence interval (CI) 0.12-0.20], P < .001} than dialysis controls, whereas a similar MACE risk to GP controls [aHR 0.81 (95% CI 0.52-1.27), P = .365]. In addition, KTRs showed a similar MACE risk compared with the GP group, regardless of age, sex and the presence of comorbidities, including hypertension, diabetes and dyslipidemia. Among KTRs, de novo MACEs were associated with an increased risk of all-cause mortality, but not with DCGF. CONCLUSIONS: De novo MACEs in KTRs were much lower than that in dialysis patients and had a similar risk to the GP, but once it occurred it caused elevated mortality risk in KTRs.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kim JE, Park J, Park S, et al. De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study. Nephrol Dial Transplant. 2023. PMID: 35396847. doi:10.1093/ndt/gfac144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。